• People
  • Practices
  • COVID-19 Resources
  • Insights
    • Firm News
    • Press Releases
    • Publications
    • Webcasts
    • Podcasts
    • Subscribe
    • Media Contacts
  • Careers
    • Career Opportunities
    • Attorney Development
    • Contact Us
  • About
    • Our Story
    • Awards & Accolades
    • Offices
    • Diversity
    • Pro Bono
    • Alumni
    • Contact Us
  • Search
  • Biography
  • Education
  • Recent Publications
Profile Picture

Christopher M. Wilson

Christopher
Wilson

Partner

CONTACT INFO

cwilson@gibsondunn.com

TEL:+1 202.955.8520

FAX:+1 202.831.6072

Washington, D.C.

1050 Connecticut Avenue, N.W., Washington, DC 20036-5306 USA

  • Print
  • |
  • Share
  • |
  • vCard

PRACTICE

Antitrust and Competition Litigation

BIOGRAPHY

Christopher M. Wilson is a partner in the Washington, D.C. office of Gibson Dunn & Crutcher.  He is a member of the firm’s Antitrust and Competition Practice Group.

Mr. Wilson assists clients in navigating DOJ, FTC, and international competition authority investigations as well as private party litigation involving complex antitrust and consumer protection issues, including matters implicating the Sherman Act, the Clayton Act, the FTC Act, the Hart-Scott-Rodino (HSR) merger review process, as well as international and state competition statutes.  His experience crosses multiple industries, including health insurance, transportation, telecommunications, technology, energy, agriculture, and biotechnology, and his particular areas of focus include merger enforcement, interlocking directorates, joint ventures, compliance programs, and employee “no-poach” agreements.  He is also well-versed in cross-border investigations involving the European Union, the United Kingdom, Canada, Brazil, Japan, Korea, and Saudi Arabia, among other jurisdictions.

Mr. Wilson is also active in the Antitrust Section of the American Bar Association, serving as Vice Chair of the Transportation & Energy Industries Committee.  He is also a member of the Section’s Health Care and Pharmaceuticals Committee, and is a frequent participant in ABA webcasts and presentations.

Prior to joining the firm, Mr. Wilson was a trial attorney in the Transportation, Energy & Agriculture Section of the U.S. Department of Justice – Antitrust Division.  During his tenure, Mr. Wilson played a prominent role in numerous high-profile matters, and he received the Antitrust Division’s Award of Distinction on two separate occasions.  Before joining the Department of Justice, Mr. Wilson was an associate in Gibson Dunn’s Dallas office.

He is a graduate of Columbia Law School, where he was a Harlan Fiske Stone scholar, and was an editor on the Columbia Business Law Review.  He holds a B.A. in Economics from New York University.

Mr. Wilson is admitted to practice in California, Texas, and the District of Columbia.

Professional Activities and Publications

Mr. Wilson currently serves as Vice Chair of the ABA Antitrust Section’s Transportation & Energy Industries Committee. He is also an Editor of the American Bar Association’s Antitrust Health Care Chronicle and Antitrust Laws & Trade Regulation: Desk Edition (published by LexisNexis). He has also been published in numerous antitrust newsletters and publications.

His representative publications and speaking engagements include:

  • Christopher M. Wilson, Interlocking Directorates under Section 8 of the Clayton Act, The Antitrust Counselor (June 2020)
  • Christopher M. Wilson, Virtual Spring Meeting Recap: Where Do Vertically Integrated Digital Platforms End?, Monopoly Matters (Spring 2020)
  • Christopher M. Wilson, State Antitrust Immunity in the Wake of Diverse Power v. City of LaGrange, Transportation, Energy & Antitrust (Spring 2020)
  • Christopher M. Wilson, The Debate Over Institutional Investor Ownership of Competing Firms, The Exchange (December 2019)
  • Lillian Okamuro, Christopher M. Wilson (Editor), Non-Price Effects Analysis in Healthcare Merger Litigation, The Antitrust Health Care Chronicle (December 2019)
  • Duk-Ki Moon, Christopher M. Wilson (Editor), Market Definition for Innovative Pharmaceuticals: How Far Should We Go?, The Antitrust Health Care Chronicle
  • Bill Batchelor, George Zacharodimos, Christopher M. Wilson (Editor), Antitrust Healthcare Chronicle Enforcer Series: An Interview with Ann Pope, Senior Director, Competition & Markets Authority, The Antitrust Health Care Chronicle
  • M. Sean Royall, Richard H. Cunningham, Christopher M. Wilson, Chris Kopp, Updated Vertical Merger Guidelines May Be on the Horizon, Washington Legal Foundation Legal Pulse
  • Eric Mahr, Christopher M. Wilson, Enforcer Insights: An Interview with Eric Mahr, Former Antitrust Division Director of Litigation, The Antitrust Health Care Chronicle
  • Christopher M. Wilson, Key Takeaways from the Dominance Divergence Task Force, Monopoly Matters (Spring 2019)
  • Moderator, “Fundamentals of Intellectual Property for Antitrust Lawyers,” ABA Webcast (April 2019)

EDUCATION

Columbia University - 2009 Juris Doctor

New York University - 2002 Bachelor of Arts

ADMISSIONS

California Bar

District of Columbia Bar

Texas Bar

RECENT PUBLICATIONS

Client Alert - February 10, 2023 | DOJ Signals Increased Scrutiny on Information Sharing
Client Alert - January 24, 2023 | FTC Publishes Revised Hart-Scott-Rodino Notification Thresholds for 2023
Client Alert - January 5, 2023 | FTC Proposes Rule to Ban Non-Compete Clauses
Press Releases - November 15, 2022 | Gibson Dunn Promotes 37 Lawyers to Partnership
Client Alert - November 14, 2022 | FTC Announces Broader Vision of Its Section 5 Authority to Address Unfair Methods of Competition
Client Alert - May 16, 2022 | The FTC at Full Strength: What to Expect Next
Client Alert - May 2, 2022 | DOJ Antitrust Division Head Promises Litigation to Break Up Director Interlocks
Client Alert - April 18, 2022 | Employers Beware: Aggressive and Expansive Labor-Focused Antitrust Enforcement Will Remain The New Normal
Client Alert - April 12, 2022 | U.S. Department of Justice and Federal Trade Commission Host Antitrust Enforcers Summit
Client Alert - March 2, 2022 | Updates and Trends in Vertical M&A Transactions
Client Alert - June 25, 2021 | Directors Resign After Department of Justice Raises Antitrust Concerns
Client Alert - February 5, 2021 | FTC and DOJ Suspend Early Termination of Merger Reviews; FTC Publishes Revised Hart-Scott-Rodino Notification Thresholds for 2021
Client Alert - December 15, 2020 | U.S. Congress Passes the Criminal Antitrust Anti-Retaliation Act of 2019
Webcasts - November 10, 2020 | Webcast: Antitrust Merger Trials – Lessons Learned and Strategies for Success
Client Alert - September 21, 2020 | Antitrust Merger Enforcement Update: DOJ Antitrust Releases New Guidelines for Merger Remedies
Client Alert - July 1, 2020 | U.S. Department of Justice and Federal Trade Commission Finalize Vertical Merger Guidelines
Client Alert - March 25, 2020 | Competitor Collaborations During COVID-19 Pandemic: Practical Antitrust Guidelines and an Update from the DOJ and FTC
Client Alert - March 19, 2020 | U.S. Antitrust Enforcers Announce Additional Changes to Merger Review Procedures
Client Alert - January 29, 2020 | Antitrust Merger Enforcement Update and Outlook
Client Alert - January 28, 2020 | U.S. Federal Trade Commission Publishes Revised Hart-Scott-Rodino Notification Thresholds for 2020
Client Alert - November 11, 2019 | DOJ Announces a New Strike Force to Combat Antitrust Misconduct in Government Procurement
Client Alert - September 16, 2019 | DOJ’s Antitrust Division Elects Binding Arbitration to Resolve Merger Challenge
Client Alert - February 19, 2019 | FTC Publishes Revised Hart-Scott-Rodino Notification Thresholds for 2019
Client Alert - November 6, 2018 | Assistant Attorney General Makan Delrahim and FTC Chairman Joe Simons Testify on Antitrust Enforcement Before Senate Subcommittee on Antitrust
Client Alert - October 1, 2018 | DOJ Antitrust Head Signals Move to Shorter, Less Burdensome Merger Review
  • Sitemap
  • Client Extranet
  • Legal Notices
  • Modern Slavery Statement
  • Privacy Policy
  • Cookie Notice
  • Contact Us
©Gibson, Dunn & Crutcher LLP 2023. All rights reserved.
Top